Health Care·Health Care Equipment·$21.8B
STERIS PLC is a leading provider of health care equipment and services, focusing on sterilization and infection prevention. As a key player in the health care sector, the company plays a crucial role in ensuring patient safety and operational efficiency in medical facilities.
Earnings Per Share (EPS)
EPS is a critical measure of the company's profitability and financial health, which investors closely watch.
Revenue Growth
While specific revenue estimates are not available, growth in revenue is essential for assessing the company's market performance.
1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
0Q
EPS Beat Rate
75%
Avg EPS Surprise
+1.68%
Avg Stock Reaction
-0.16%
In the last quarter, STERIS reported an EPS of $2.53, matching analyst expectations with a slight surprise. The stock reacted positively, gaining nearly 1% the following day.
Management Promises & Guidance
Overall expectations for STERIS's upcoming earnings are cautiously optimistic, given their strong EPS track record. Investors are keen to see if the company can maintain its growth trajectory amidst market challenges.
Bull Case
If STERIS exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its products and services, leading to a positive stock reaction.
Bear Case
Conversely, if the company fails to meet EPS expectations or shows signs of declining revenue, it could raise concerns about its competitive position and lead to a negative market response.
Earnings Per Share (EPS)
$2.53EPS is a critical measure of the company's profitability and financial health, which investors closely watch.
Revenue Growth
N/AWhile specific revenue estimates are not available, growth in revenue is essential for assessing the company's market performance.
Operating Margin
N/AThis metric will help investors gauge the efficiency of STERIS's operations and cost management.
The print will turn on these two things.
Q1
Will the EPS exceed $2.53, indicating continued profitability?
Given STERIS's strong historical performance, a beat on EPS could reinforce investor confidence and drive stock prices higher.
Q2
What insights can management provide on revenue growth trends?
Understanding revenue trends is crucial for assessing the company's market position and future growth potential.
Why consensus could be wrong
The market may underestimate STERIS's ability to leverage new technologies in sterilization, which could drive unexpected revenue growth.
Supporting Evidence
The company's historical EPS beat rate of 88% suggests a strong likelihood of exceeding expectations.
Recent trends in health care spending indicate increased demand for sterilization equipment.
Options pricing suggests a higher expected move than historical averages, indicating potential for significant stock movement.
Key Risk
If STERIS reports an EPS below $2.50, it could challenge the current bullish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance hinges on STERIS's ability to maintain profitability and revenue growth in a competitive health care market.
Bull Confirmed If
An EPS of $2.60 or higher would confirm the bull case and suggest strong operational performance.
Bear Confirmed If
An EPS below $2.50 would support the bear case, raising concerns about profitability.
Implied Move
±7.80%
Historical Avg
±0.9%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±7.8% while STE has averaged ±0.9% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If STERIS beats expectations, history suggests the stock could rise by around 0.99%, confirming strong demand and operational efficiency.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.
Miss
A miss could lead to a decline of approximately 1.19%, reflecting investor disappointment and concerns about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ENBRIDGE INC
May 8, 2026